Usual Adult Dose for Thrombocytopenia

3 mg orally once a day starting 8 to 14 days prior to a scheduled procedure

Duration of therapy: 7 days

Comments: Patients should undergo their procedure 2 to 8 days after the last dose.

Use: Treatment of thrombocytopenia in patients with chronic liver disease who are scheduled to undergo a procedure.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

This drug should not be used to normalize platelet counts in patients with chronic liver disease.

Precautions

CONTRAINDICATIONS: None

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• May be taken with or without food.
• Patients should take a missed dose as soon as possible on the same day and return to the normal schedule the following day.

• Hematologic: Platelet count (before starting this drug and not more than 2 days before the procedure)

• Advise women of reproductive potential who become pregnant or are planning to become pregnant that this drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.
• Advise women not to breastfeed during use of this drug and for at least 28 days after the last dose. Advise women to pump and discard breast milk during this period.

Frequently asked questions

• Mulpleta vs Doptelet - What's the difference?